Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps

Bartłomiej Matejko 1, Małgorzata Grzanka 1, Beata Kieć-Wilk 1, Maciej T Małecki 1, Tomasz Klupa 1
1 - Department and Chair of Metabolic Diseases, Jagiellonian University, Krakow, Poland
Ann Agric Environ Med
2013; 20 (1):
ICID: 1041690
Article type: Original article
Introduction and Objective. The ability to perceive the symptoms of hypoglycemia during the early decrease in plasma glucose concentration may be critical for the safety of T1DM patients treated with intensive insulin therapy, including those treated with continuous subcutaneous insulin infusion (CSII). In the presented observational study an attempt was made to asses clinical factors that might affect subjective awareness of hypoglycemia in CSII-treated T1DM patients, with special attention to factors specific for this mode of treatment.
Materials and Methods. For the purpose of the study, data of 110 CSII-treated T1DM patients were collected (78 females and 32 males). The records were analyzed from glucose meters (200-300 measurements/download, depending on meter type) and insulin pumps (total insulin dose, basal/bolus ratio, number of boluses/day, bolus calculator and dual wave/square bolus usage, continuous glucose monitoring data) from the last 3 years.
Results. It was found that the level of subjective hypoglycemia perception inversely correlated with the number of hypoglycemic episodes per 100 measurements, age, duration of diabetes, time on insulin pump, and positively correlated with mean glycemia (n = 98; r = 0.22; p = 0.0286). With respect to CSII-related factors, hypoglycemia perception inversely correlated with the percentage of basal insulin (n = 106; r = -0.20; p = 0.0354). In stepwise regression analysis, independent predictors for impaired hypoglycemia perception were: age β = -0.29 (p = 0.023), duration of diabetes β = -0.24 (p = 0.029) and number of the hypoglycemia episodes for 100 measurements β = -0.33 (p = 0.0005).
Conclusions. Risk factors for impaired hypoglycemia perception in CSII-treated patients include those identified previously for the general population of T1DM individuals. In addition, the presented results suggest that a higher basal/bolus ratio may lead to impairment of the ability to perceive early symptoms of hypoglycemia.
PMID 23540230 - click here to show this article in PubMed

Recommend this article to:


Related articles in IndexCopernicus™
     hypoglycemia perception [0 related records]
     diabetes [969 related records]
     continuous subcutaneous insulin infusion (CSII) [1 related records]
     insulin pump [7 related records]


Related articles

, ,
 عصاره آبی گیاه چرخه (Launaea...
 چکیدهزمینه و هدف: افزایش مقاومت انسولین، فاکتورهاي التهابی و پارامترهاي استرس اکسیداتیو با پیشرفت دیابت مرتبط است. گیاه چرخه دارای تر...
Effect and mechanism of pyrrolidine dithiocarbamat...
<b>OBJECTIVE</b> To investigate the protective effects and mechanisms of pyrrolidine dithio-carbamate(PDTC) against the impairment of endothelium-dependent vasodilation function in diabetic rats. <b>METHODS</b> A diabetic mode...
K  Rezaee, J Haddadnia,
Intelligent and Online Evaluation of Diabetes usin...
Objective: International Diabetes Organization estimates that there are 285 million people worldwide who suffer from diabetes, and this figure is expected to increase to 450 million in next 20 years. According to statistics issued by the World Health...